- Home
- NVX vs GNFT Comparison
NVX vs GNFT Comparison
Compare NVX & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVX
- GNFT
- Stock Information
- Founded
- NVX 2012
- GNFT 1999
- Country
- NVX Australia
- GNFT France
- Employees
- NVX N/A
- GNFT N/A
- Industry
- NVX Industrial Machinery/Components
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NVX Miscellaneous
- GNFT Health Care
- Exchange
- NVX Nasdaq
- GNFT Nasdaq
- Market Cap
- NVX 176.8M
- GNFT 186.3M
- IPO Year
- NVX N/A
- GNFT 2019
- Fundamental
- Price
- NVX $1.17
- GNFT $3.80
- Analyst Decision
- NVX
- GNFT Strong Buy
- Analyst Count
- NVX 0
- GNFT 1
- Target Price
- NVX N/A
- GNFT $13.00
- AVG Volume (30 Days)
- NVX 389.6K
- GNFT 3.0K
- Earning Date
- NVX 01-01-0001
- GNFT 09-18-2025
- Dividend Yield
- NVX N/A
- GNFT N/A
- EPS Growth
- NVX N/A
- GNFT N/A
- EPS
- NVX N/A
- GNFT 0.03
- Revenue
- NVX $5,854,424.00
- GNFT $73,187,701.00
- Revenue This Year
- NVX $135.22
- GNFT $5.15
- Revenue Next Year
- NVX $1,647.66
- GNFT N/A
- P/E Ratio
- NVX N/A
- GNFT $124.11
- Revenue Growth
- NVX N/A
- GNFT 105.01
- 52 Week Low
- NVX $0.81
- GNFT $2.55
- 52 Week High
- NVX $2.73
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- NVX 42.46
- GNFT 45.09
- Support Level
- NVX $1.51
- GNFT $3.94
- Resistance Level
- NVX $2.04
- GNFT $4.19
- Average True Range (ATR)
- NVX 0.19
- GNFT 0.11
- MACD
- NVX -0.04
- GNFT 0.01
- Stochastic Oscillator
- NVX 6.45
- GNFT 24.06
About NVX NOVONIX Limited American Depository Shares
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration, Battery Technology, and Battery Materials. Graphite Exploration segment is engaged in the exploration and development of high-grade flake graphite deposits. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment generates maximum revenue for the company.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.